PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo

E-ISSN： 1532-6535|91|6|1044-1052

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.6, 2012-06, pp. : 1044-1052

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 510-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 189-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction Data

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 179-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sertraline‐induced potentiation of the CYP3A4‐dependent neurotoxicity of carbamazepine: An in vitro study

EPILEPSIA, Vol. 56, Iss. 3, 2015-03 ,pp. : 439-449

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2604-2617

John Wiley & Sons Inc

Access to resources Recommend Favorite